- Home
- RVPH vs DM Comparison
RVPH vs DM Comparison
Compare RVPH & DM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- DM
- Stock Information
- Founded
- RVPH 2006
- DM 2015
- Country
- RVPH United States
- DM United States
- Employees
- RVPH N/A
- DM N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- DM Industrial Machinery/Components
- Sector
- RVPH Health Care
- DM Technology
- Exchange
- RVPH Nasdaq
- DM Nasdaq
- Market Cap
- RVPH 88.0M
- DM 87.7M
- IPO Year
- RVPH N/A
- DM N/A
- Fundamental
- Price
- RVPH $1.04
- DM $2.04
- Analyst Decision
- RVPH Strong Buy
- DM Hold
- Analyst Count
- RVPH 5
- DM 1
- Target Price
- RVPH $11.40
- DM $5.50
- AVG Volume (30 Days)
- RVPH 1.1M
- DM 194.1K
- Earning Date
- RVPH 05-13-2025
- DM 05-08-2025
- Dividend Yield
- RVPH N/A
- DM N/A
- EPS Growth
- RVPH N/A
- DM N/A
- EPS
- RVPH N/A
- DM N/A
- Revenue
- RVPH N/A
- DM $168,283,000.00
- Revenue This Year
- RVPH N/A
- DM N/A
- Revenue Next Year
- RVPH N/A
- DM $6.25
- P/E Ratio
- RVPH N/A
- DM N/A
- Revenue Growth
- RVPH N/A
- DM N/A
- 52 Week Low
- RVPH $0.60
- DM $1.84
- 52 Week High
- RVPH $4.28
- DM $11.80
- Technical
- Relative Strength Index (RSI)
- RVPH 25.55
- DM 41.25
- Support Level
- RVPH $1.12
- DM $1.84
- Resistance Level
- RVPH $1.23
- DM $2.08
- Average True Range (ATR)
- RVPH 0.13
- DM 0.15
- MACD
- RVPH -0.03
- DM -0.01
- Stochastic Oscillator
- RVPH 0.00
- DM 36.94
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About DM Desktop Metal Inc.
Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.